MOSCOW, July 4 – RIA Novosti. In a statement to the Roszdravnadzor press service of RIA Novosti, it was reported that the American pharmaceutical company MSD has decided to stop the delivery of rubella, measles and mumps vaccines to Russia.

By law, pharmaceutical manufacturers or importers are required to inform the Russian authorities at least one year in advance if the production or supply of drugs is stopped.

Roszdravnadzor emphasized that “There are enough vaccines on the market for the prevention of Russian-made chickenpox and measles, rubella and mumps”.

In response, Deputy Minister of Health Alexei Kuznetsov told RIA Novosti that vaccines against these diseases were purchased centrally in Russia from a domestic manufacturer and the need was fully met.

Earlier, the American pharmaceutical company Eli Lilly had suspended investments, clinical trials and imports of some of its drugs into Russia. Abbvie, which also owns the Allergan brand, which calls Botox a cosmetic procedure, also announced that its consumables are frozen.

In April, Prime Minister Mikhail Mishustin noted that there may be difficulties in the delivery of medicines due to external pressure and disruption of supply chains. The authorities are taking action: they have launched a special program specifically to support the backbone businesses of the pharmaceutical and medical industries.